What is Cellyan Biotechnology Co., Ltd's Shariah compliance score?

Cellyan Biotechnology Co., Ltd (HKPD) has a Shariah compliance score of 72/100 (Grade: B+, Good) based on AAOIFI screening standards. Scores above 70 typically indicate strong compliance. The score factors in business activity screening and financial ratio analysis including debt levels, interest-bearing deposits, and prohibited income percentages. View the full breakdown at HalalScreener.app.

Does Cellyan Biotechnology Co., Ltd pass AAOIFI screening?

Cellyan Biotechnology Co., Ltd (HKPD) partially passes with caution AAOIFI Shariah screening. AAOIFI requires: (1) no primary involvement in prohibited activities like alcohol, gambling, or conventional banking, (2) debt-to-market-cap below 30% (HKPD: 28.8%), (3) interest-bearing deposits below 30%, and (4) prohibited income below 5%. HalalScreener provides free AAOIFI screening for 6,200+ stocks at halalscreener.app.

How much purification is needed for Cellyan Biotechnology Co., Ltd stock?

Muslim investors purify the portion of dividends and realized gains that comes from non-permissible income by donating it to charity. HalalScreener's purification calculator at halalscreener.app/en/purification computes the exact percentage and amount for Cellyan Biotechnology Co., Ltd (HKPD) using the latest financial data.

Where can I screen Cellyan Biotechnology Co., Ltd for Shariah compliance for free?

HalalScreener (halalscreener.app) offers free Shariah compliance screening for Cellyan Biotechnology Co., Ltd (HKPD) and 5,100+ other US-listed stocks, ETFs, and 100+ cryptocurrencies. The screening uses AAOIFI Standard No. 21 and shows the verdict, compliance grade, score, and debt ratio free. No credit card or signup required for basic screening; the full ratio breakdown is part of Pro. HalalScreener also includes an AI Islamic Scholar for follow-up questions about HKPD's compliance across different madhabs (Hanafi, Shafi'i, Maliki, Hanbali, Ja'fari).

HKPD: Is Cellyan Biotechnology Co., Ltd Halal?

Cellyan Biotechnology Co., Ltd

NASDAQHealthcareHK

$0.40

+6.99%

Market Cap: 4.4M

Compliance Status

Doubtful

Screened on Aug 26, 2026 · AAOIFI Standard 21

B+

Good

72Score

Is Cellyan Biotechnology Co., Ltd (HKPD) halal? Doubtful. Based on AAOIFI screening, Cellyan Biotechnology Co., Ltd passes the business activity screen but has financial ratios approaching AAOIFI limits with a compliance score of 72/100 (Grade: B+).

AvoidBorderlineClean

Business activity

What the company sells is permissible.

Passed

Company debt

Close to the limit

How much the company borrows, compared to its total value. AAOIFI allows up to 30%.

28.8% of 30.0% limit

What this means for you

You may own HKPD, with caution

Its numbers sit close to AAOIFI limits. Cautious investors may prefer alternatives or ask a scholar first.

Purification amount is Pro

We have screened HKPD's prohibited income, but the exact share you would need to purify is part of Pro.

About Cellyan Biotechnology Co., Ltd

Cellyan Biotechnology Co., Ltd, an investment holding entity, primarily operates within the over-the-counter (OTC) pharmaceutical sector, serving markets across Hong Kong and mainland China. The company's services encompass the international sourcing and distribution of OTC medications, alongside comprehensive e-commerce supply chain management. Furthermore, it provides essential logistical support, including customs clearance, drug registration, and warehousing facilities. Cellyan Biotechnology caters to a diverse clientele, which includes logistics partners for e-commerce platforms, various merchants, and pharmaceutical distributors. Founded in 2023, the company is based in Yau Tong, Hong Kong. It was formerly known as Hong Kong Pharma Digital Technology Holdings Limited and officially adopted the name Cellyan Biotechnology Co., Ltd in December 2025.

Sector: Healthcare · Industry: Medical - Distribution

Why This Stock Is Doubtful

Debt is 28.8% of market cap, only 1.2 points below the 30% AAOIFI limit

Stocks are marked Doubtful when financial ratios pass but approach AAOIFI thresholds. Consider consulting a qualified scholar for a definitive ruling.

Shariah Compliance Status

AAOIFI Standard 21Updated Aug 26, 2026

Compliance History

Doubtful, unchanged since Aug 2026.

No status changes recorded since we began tracking.

Tracked since Aug 2026. Updates automatically on each re-screen.

Fiscal: FY 2026Data source: FMP

More Healthcare Stocks

JNJ

Johnson & Johnson

UNH

UnitedHealth Group Incorporated

ABBV

AbbVie Inc.

PFE

Pfizer Inc.

LLY

Eli Lilly and Company

A+

MRK

Merck & Co., Inc.

Free · No credit card required

Track HKPD and 6,200+ stocks with AI insights

Create your free account to unlock AI-powered compliance analysis, track your portfolio, calculate purification, and get unlimited AAOIFI screening.

Get Started Free Browse Screener

6,200+ assets AAOIFI standards Free watchlist

Frequently Asked Questions

Is Cellyan Biotechnology Co., Ltd (HKPD) halal to invest in?

Cellyan Biotechnology Co., Ltd (HKPD) is rated Doubtful under AAOIFI Standard 21. It passes the business activity screen but one or more financial ratios are approaching (though not yet exceeding) the AAOIFI thresholds (30% for debt and interest deposits, 5% for prohibited income). Consult a qualified Islamic finance scholar for a personal ruling.

Why did Cellyan Biotechnology Co., Ltd get a B+ compliance rating?

Cellyan Biotechnology Co., Ltd (HKPD) received a grade of B+ (Good) based on three AAOIFI Standard 21 financial ratios: debt-to-market-cap of 28.8% (limit 30%). The grade reflects the margin of safety across all three ratios relative to their thresholds.

What could change Cellyan Biotechnology Co., Ltd's Shariah verdict?

Cellyan Biotechnology Co., Ltd's verdict is re-evaluated at each annual re-screen. Three events could change it: (1) the debt-to-market-cap ratio crossing 30%, typically from new debt issuance or a major drop in share price; (2) interest-bearing deposits exceeding 30% of market cap; or (3) prohibited revenue (alcohol, gambling, conventional finance, etc.) exceeding 5% of total revenue. Verdict flips are tracked in the compliance history section above.

How often is Cellyan Biotechnology Co., Ltd re-screened for Shariah compliance?

Cellyan Biotechnology Co., Ltd (HKPD) is re-screened annually using the most recent full-year financial data from SEC filings. HalalScreener also triggers an on-demand re-screen whenever the stored data is more than 7 days old, ensuring the ratios reflect the latest available financial statements. Last screened: Aug 26, 2026.

Screened according to AAOIFI Standard No. 21 · For informational purposes only. Consult a qualified Islamic finance advisor before investing.

Disclaimer: This screening is for informational purposes only and does not constitute financial, legal, or religious advice. Compliance is evaluated using AAOIFI financial standards (debt, deposits, and prohibited income ratios) and publicly available data. Ethical, political, social, or environmental considerations are outside the scope of this screening. Individual scholars and methodologies may differ. Always consult a qualified Islamic finance advisor before making investment decisions.